These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


122 related items for PubMed ID: 1435320

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
    Puri RN, Zhou FX, Bradford H, Hu CJ, Colman RF, Colman RW.
    Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of ADP-induced platelet responses by covalent modification of aggregin, a putative ADP receptor, by 8-(4-bromo-2,3-dioxobutylthio)ADP.
    Puri RN, Kumar A, Chen H, Colman RF, Colman RW.
    J Biol Chem; 1995 Oct 13; 270(41):24482-8. PubMed ID: 7592664
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.
    Mills DC, Puri R, Hu CJ, Minniti C, Grana G, Freedman MD, Colman RF, Colman RW.
    Arterioscler Thromb; 1992 Apr 13; 12(4):430-6. PubMed ID: 1558834
    [Abstract] [Full Text] [Related]

  • 8. Platelet activation: role of an ADP receptor.
    Colman RW.
    Semin Hematol; 1986 Apr 13; 23(2):119-28. PubMed ID: 3010469
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition of ADP-induced platelet shape change and aggregation by o-phthalaldehyde: evidence for covalent modification of cysteine and lysine residues.
    Puri RN, Colman RW.
    Arch Biochem Biophys; 1991 May 01; 286(2):419-27. PubMed ID: 1910292
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunoaffinity method to identify aggregin, a putative ADP-receptor in human blood platelets.
    Puri RN, Colman RW.
    Arch Biochem Biophys; 1997 Nov 15; 347(2):263-70. PubMed ID: 9367534
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. II. Quantal activation parallels platelet capture in stir-associated microaggregation.
    Frojmovic MM, Mooney RF, Wong T.
    Biophys J; 1994 Nov 15; 67(5):2069-75. PubMed ID: 7858144
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A novel method for chemical modification of functional groups other than a carboxyl group in proteins by N-ethyl-5-phenylisooxazolium-3'-sulfonate (Woodward's reagent-K): inhibition of ADP-induced platelet responses involves covalent modification of aggregin, an ADP receptor.
    Puri RN, Colman RW.
    Anal Biochem; 1996 Sep 05; 240(2):251-61. PubMed ID: 8811919
    [Abstract] [Full Text] [Related]

  • 19. Aggregin: the platelet receptor mediating activation by ADP.
    Colman RW, Puri RN, Zhou FX, Colman RF.
    Prog Clin Biol Res; 1988 Sep 05; 283():263-77. PubMed ID: 3211953
    [No Abstract] [Full Text] [Related]

  • 20. Identification of two distinct adenosine diphosphate receptors in human platelets.
    Colman RW, Figures WR, Colman RF, Morinelli TA, Niewiarowski S, Mills DC.
    Trans Assoc Am Physicians; 1980 Sep 05; 93():305-16. PubMed ID: 6264660
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.